FDA warns Bristol’s leukemia drug may raise lung risks (Reuters)
Reuters – Health regulators warned on Tuesday that Bristol-Myers Squibb Co’s leukemia drug Sprycel may raise the risk of a rare, but serious condition characterized by abnormally high blood pressure in the arteries of the lungs.
View full post on Yahoo! News: Health News
Leave a Reply